Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed + S-1 real-world study in previously treated metastatic colorectal cancer
ChiCTR2000030339Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of raltitrexed and tegafur in metastatic colorectal adenocarcinoma (mCRC), sponsored by West China Hospital of Sichuan University. Primary endpoint: Objective response rate. Started Mar 2020; status: recruiting.
02
Drugs
raltitrexedtegafur
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on ChiCTR2000030339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030339.